Impact of risk-reducing salpingo-oophorectomy in premenopausal womenR. F. M. Vermeulen, Gemma G. Kenter, Catharina M. Korse et al.|Climacteric|2017Cited by 62
Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective studyR. F. M. Vermeulen, Neil K. Aaronson, Eveline M. A. Bleiker et al.|European Journal of Cancer|2017Cited by 50
The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: A systematic reviewJudith Spekreijse, Marc van Beurden, Bianca M.M. Streng et al.|Gynecologic Oncology|2020Cited by 42
Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelinesR. F. M. Vermeulen, Marc van Beurden, Catharina M. Korse et al.|Climacteric|2019Cited by 37
The Vulvar Cancer Risk in Differentiated Vulvar Intraepithelial Neoplasia: A Systematic ReviewFéline O. Voss, Maaike C.G. Bleeker, Nikki B. Thuijs et al.|Cancers|2021Cited by 33